CORPORATES Biocon Biologics gets marketing authorisation from EC for Denosumab Biosimilars Vevzuo and Evfraxy Jul 3, 2025
CORPORATES Biocon Biologics crosses 100 million insulin cartridge deliveries in Malaysia Jun 30, 2025
Biocon Biologics partners with NCSM to launch Cancer Patient Assistance Program in Malaysia Jun 24, 2025
Biocon’s subsidiary refinances USD 1.1 Billion long-term debt through USD bonds and new syndicated facility Oct 3, 2024
Biocon Biologics announces pivotal Phase 3 results on Adalimumab Interchangeability at EADV 2024 Congress Sep 25, 2024
Biocon Biologics secures exclusive distribution rights for Adalimumab Biosimilar in Japan Dec 22, 2023
Pandemic hits Biocon: 18% drop in net profit, MD Christiane Hamacher resigns & shares drop 9.11% Jan 22, 2021